The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients. By Christina Jewett and Roni Caryn Rabin from NYT Health https://ift.tt/7bizqxa
Comments
Post a Comment